Clark Capital Management Group »

Catalyst Pharmaceutical Partners shares owned by Clark Capital Management Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Clark Capital Management Group from 13F filings

Historical chart of Clark Capital Management Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Clark Capital Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Clark Capital Management Group

Quarter filed Position value Share count Share price at filing
2025-06-30 $8.5M 392k 21.70
2025-03-31 $5.9M 245k 24.25
2024-12-31 $4.3M 208k 20.87
2023-09-30 $2.3M 199k 11.69
2023-06-30 $2.1M 153k 13.44
2023-03-31 $2.4M 142k 16.58

More positions owned by Clark Capital Management Group

Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Series Trust Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust Bloomberg High Y (JNK)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Total (IXUS)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Nvent Electric SHS (NVT)
Johnson & Johnson (JNJ)
Abbvie (ABBV)

View all positions for Clark Capital Management Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management
Northern Trust

View all funds holding Catalyst Pharmaceutical Partners